Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease which is characterized by chronic airflow limitation and a range of pathological changes in the lung, significant extra-pulmonary effects, and important comorbidities which may contribute to the severity of the disease in individual patients. COPD refers to a disease that causes airflow blockage and breathing-related problems including emphysema, chronic bronchitis, or both¹.

Managing Chronic Obstructive Pulmonary Disease Learning Collaborative
The Best Practices Learning Collaborative is for organizations that are striving to improve the care of patients with COPD. Working together, we will develop an optimal care framework that includes a comprehensive, patient-centered, value-based approach to chronic care. Participating project teams will be able to regularly network with peers, participate in bi-monthly conference calls on relevant project topics, attend two in-person meetings, and have timely access to industry experts. Through a yearlong series of activities, participating organizations will have the opportunity to test approaches and design care processes that are relevant to their clinical and operational models.

Seven medical groups have been awarded $10,000 grants to support their initiatives; an additional 5 organizations are supported with travel stipends to attend the collaborative meetings. The learning collaborative will commence in November 2010 and concluded in November 2011.

2010 - 2011 Learning Collaborative Members Only

If you have questions or need further information, contact Danielle Flowers at dflowers@amga.org or at (703) 838-0033, ext. 347.

¹ Global Initiative for Chronic Obstructive Lung Disease Executive Committee. Global strategy for the diagnosis, managements, and prevention of chronic obstructive pulmonary disease. Medical Communications Resources, Inc; 2009.

Website Terms and Conditions of Use and Privacy Policy